Processa Pharmaceuticals (PCSA) Institutional Ownership $1.15 -0.01 (-0.86%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Processa Pharmaceuticals (NASDAQ:PCSA)CurrentInstitutional OwnershipPercentage91.93%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$514.38KNumber ofInstitutional Sellers(last 12 months)0 Get PCSA Insider Trade Alerts Want to know when executives and insiders are buying or selling Processa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PCSA Institutional Buying and Selling by Quarter Ad Porter & CompanyNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Processa Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/2/2024 Spinnaker Trust76,865$26K0.0%N/A6.249% 8/5/2022Coastal Bridge Advisors LLC52,500$148K0.0%+61.5%0.331% 2/15/2022Coastal Bridge Advisors LLC32,500$159K0.0%+18.2%0.207% 2/10/2022AIGH Capital Management LLC303,703$1.49M0.5%-21.5%1.932% 1/26/2022Verdence Capital Advisors LLC63,227$310K0.0%-14.3%0.402% 10/29/2021 Janney Montgomery Scott LLC46,231$396K0.0%-18.5%0.296% 8/16/2021State Street Corp16,600$136K0.0%N/A0.107% 8/13/2021Geode Capital Management LLC37,400$306K0.0%+34.4%0.240% 8/13/2021Vanguard Group Inc.373,171$3.06M0.0%+136.7%2.397% 8/10/2021Coastal Bridge Advisors LLC27,500$225K0.0%+37.5%0.177% 8/9/2021Vectors Research Management LLC4,000$33K0.0%N/A0.026% 5/21/2021Citadel Advisors LLC13,117$143K0.0%N/A0.085% 5/19/2021Worth Venture Partners LLC90,968$942K0.5%N/A0.586% 5/18/2021Millennium Management LLC93,999$1.03M0.0%-12.0%0.606% 5/18/2021Citadel Advisors LLC13,117$143K0.0%N/A0.085% 5/17/2021Coastal Bridge Advisors LLC20,000$218K0.0%N/A0.129% 5/12/2021Northern Trust Corp12,845$140K0.0%N/A0.083% 5/12/2021Geode Capital Management LLC27,825$303K0.0%N/A0.179% 5/12/2021 Essex Investment Management Co. LLC72,908$795K0.1%-2.7%0.470% 5/4/2021Commonwealth Equity Services LLC10,550$115K0.0%N/A0.068% 4/27/2021 Janney Montgomery Scott LLC63,331$690K0.0%-4.5%0.408% 2/13/2021 Essex Investment Management Co. LLC74,928$494K0.1%N/A0.709% (Data available from 1/1/2016 forward) PCSA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PCSA shares? During the previous two years, the following institutional investors and hedge funds held shares of Processa Pharmaceuticals shares: Spinnaker Trust ($26K).Learn more on PCSA's institutional investors. What percentage of Processa Pharmaceuticals stock is owned by institutional investors? 91.93% of Processa Pharmaceuticals stock is owned by institutional investors. Learn more on PCSA's institutional investor holdings. Which institutional investors have been buying Processa Pharmaceuticals stock? The following institutional investors have purchased Processa Pharmaceuticals stock in the last 24 months: Spinnaker Trust ($76.87K). How much institutional buying is happening at Processa Pharmaceuticals? Institutional investors have bought a total of 76,865 shares in the last 24 months. This purchase volume represents approximately $514.38K in transactions. Related Companies Oncternal Therapeutics Major Shareholders Sol-Gel Technologies Major Shareholders Synlogic Major Shareholders GeoVax Labs Major Shareholders HCW Biologics Major Shareholders ImmunoPrecise Antibodies Major Shareholders Talphera Major Shareholders Marinus Pharmaceuticals Major Shareholders AIM ImmunoTech Major Shareholders NLS Pharmaceutics Major Shareholders This page (NASDAQ:PCSA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Processa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
